https://www.biotechblueprint.com/p/washington-tries-to-outcompete-chinaBiotech Blueprinten2026-06-26T12:30:51+00:00Washington Tries to Outcompete China, Lilly’s $1.9B Abbisko Bet, and Pfizer’s $43B Seagen Question – This Week in Biotech #106